These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 31408208)
21. Altered timing of riboflavin and ultraviolet light pathogen inactivation improves platelet in vitro quality. Schubert P; Culibrk B; Karwal S; Serrano K; Levin E; Yi Q; Thiele T; Greinacher A; Marschner S; Devine DV Transfusion; 2017 Aug; 57(8):2026-2034. PubMed ID: 28500654 [TBL] [Abstract][Full Text] [Related]
22. Characterization of plasma protein activity in riboflavin and UV light-treated fresh frozen plasma during 2 years of storage at -30 degrees C. Bihm DJ; Ettinger A; Buytaert-Hoefen KA; Hendrix BK; Maldonado-Codina G; Rock G; Giclas PC; Goodrich RP Vox Sang; 2010 Feb; 98(2):108-15. PubMed ID: 19719460 [TBL] [Abstract][Full Text] [Related]
23. p38MAPK is involved in apoptosis development in apheresis platelet concentrates after riboflavin and ultraviolet light treatment. Chen Z; Schubert P; Culibrk B; Devine DV Transfusion; 2015 Apr; 55(4):848-57. PubMed ID: 25385501 [TBL] [Abstract][Full Text] [Related]
24. The pathogen-reduced red blood cell suspension: single centre study of clinical safety and efficacy in children with oncological and haematological diseases. Trakhtman P; Kumukova I; Starostin N; Borsakova D; Balashov D; Ignatova A; Kadaeva L; Novichkova G; Rumiantcev A Vox Sang; 2019 Apr; 114(3):223-231. PubMed ID: 30784069 [TBL] [Abstract][Full Text] [Related]
25. Blood component separation of pathogen-reduced whole blood by the PRP method produces acceptable red cells but platelet yields and function are diminished. Herzig MC; Fedyk CG; Montgomery RK; Schaffer BS; Bynum JA; Pidcoke HF; Cap AP Transfusion; 2020 Jun; 60 Suppl 3():S124-S133. PubMed ID: 32478864 [TBL] [Abstract][Full Text] [Related]
26. Quality of proteins in riboflavin and UV light-treated FFP during 1 year of storage at -18°C. Ettinger A; Miklauz MM; Hendrix BK; Bihm DJ; Maldonado-Codina G; Goodrich RP Transfus Apher Sci; 2012 Feb; 46(1):15-8. PubMed ID: 22115607 [TBL] [Abstract][Full Text] [Related]
27. Functional characteristics of apheresis-derived platelets treated with ultraviolet light combined with either amotosalen-HCl (S-59) or riboflavin (vitamin B2) for pathogen-reduction. Picker SM; Oustianskaia L; Schneider V; Gathof BS Vox Sang; 2009 Jul; 97(1):26-33. PubMed ID: 19302416 [TBL] [Abstract][Full Text] [Related]
28. Determination of eicosanoid and cytokine production in salvaged blood, stored red blood cell concentrates, and whole blood. Jacobi KE; Wanke C; Jacobi A; Weisbach V; Hemmerling TM J Clin Anesth; 2000 Mar; 12(2):94-9. PubMed ID: 10818321 [TBL] [Abstract][Full Text] [Related]
29. Riboflavin and UV light treatment of platelets: a protective effect of platelet additive solution? van der Meer PF; Bontekoe IJ; Daal BB; de Korte D Transfusion; 2015 Aug; 55(8):1900-8. PubMed ID: 25752624 [TBL] [Abstract][Full Text] [Related]
30. The effects of red blood cell preparation method on in vitro markers of red blood cell aging and inflammatory response. Radwanski K; Garraud O; Cognasse F; Hamzeh-Cognasse H; Payrat JM; Min K Transfusion; 2013 Dec; 53(12):3128-38. PubMed ID: 23461802 [TBL] [Abstract][Full Text] [Related]
31. Enhancing uniformity and overall quality of red cell concentrate with anaerobic storage. Yoshida T; Blair A; D'alessandro A; Nemkov T; Dioguardi M; Silliman CC; Dunham A Blood Transfus; 2017 Mar; 15(2):172-181. PubMed ID: 28263176 [TBL] [Abstract][Full Text] [Related]
32. Treatment of whole blood (WB) and red blood cells (RBC) with S-303 inactivates pathogens and retains in vitro quality of stored RBC. Mufti NA; Erickson AC; North AK; Hanson D; Sawyer L; Corash LM; Lin L Biologicals; 2010 Jan; 38(1):14-9. PubMed ID: 19995680 [TBL] [Abstract][Full Text] [Related]
33. Treatment of platelets with riboflavin and ultraviolet light mediates complement activation and suppresses monocyte interleukin-12 production in whole blood. Loh YS; Dean MM; Johnson L; Marks DC Vox Sang; 2015 Nov; 109(4):327-35. PubMed ID: 25975771 [TBL] [Abstract][Full Text] [Related]
34. Effects of riboflavin and ultraviolet light treatment on pathogen reduction and platelets. Yin Y; Li L; Gong L; Xu H; Liu Z Transfusion; 2020 Nov; 60(11):2647-2654. PubMed ID: 32866308 [TBL] [Abstract][Full Text] [Related]
35. Prevention of red cell storage lesion: a comparison of five different additive solutions. Lagerberg JW; Korsten H; Van Der Meer PF; De Korte D Blood Transfus; 2017 Sep; 15(5):456-462. PubMed ID: 28488968 [TBL] [Abstract][Full Text] [Related]
36. Treatment of blood with a pathogen reduction technology using ultraviolet light and riboflavin inactivates Ebola virus in vitro. Cap AP; Pidcoke HF; Keil SD; Staples HM; Anantpadma M; Carrion R; Davey RA; Frazer-Abel A; Taylor AL; Gonzales R; Patterson JL; Goodrich RP Transfusion; 2016 Mar; 56 Suppl 1(Suppl 1):S6-15. PubMed ID: 27001363 [TBL] [Abstract][Full Text] [Related]
37. In vitro study of platelet function confirms the contribution of the ultraviolet B (UVB) radiation in the lesions observed in riboflavin/UVB-treated platelet concentrates. Abonnenc M; Sonego G; Crettaz D; Aliotta A; Prudent M; Tissot JD; Lion N Transfusion; 2015 Sep; 55(9):2219-30. PubMed ID: 25873361 [TBL] [Abstract][Full Text] [Related]
38. Damage to red blood cells during whole blood storage. Oh JY; Marques MB; Xu X; Li J; Genschmer K; Gaggar A; Jansen JO; Holcomb JB; Pittet JF; Patel RP J Trauma Acute Care Surg; 2020 Aug; 89(2):344-350. PubMed ID: 32301878 [TBL] [Abstract][Full Text] [Related]
39. AS-7 improved in vitro quality of red blood cells prepared from whole blood held overnight at room temperature. Veale MF; Healey G; Sran A; Payne KA; Zia M; Sparrow RL Transfusion; 2015 Jan; 55(1):108-14. PubMed ID: 25039791 [TBL] [Abstract][Full Text] [Related]
40. Plasma constituent integrity in pre-storage vs. post-storage riboflavin and UV-light treatment--a comparative study. Balint B; Jovicic-Gojkov D; Todorovic-Balint M; Subota V; Pavlovic M; Goodrich R Transfus Apher Sci; 2013 Dec; 49(3):434-9. PubMed ID: 23820430 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]